Stocktoria
Solventum Corp SOLV
Solventum Corp financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $8.3B | $8.3B | $8.2B |
| Gross profit | $4.5B | $4.6B | $4.7B |
| R&D expense | $739.0M | $775.0M | $758.0M |
| SG&A expense | $3.1B | $2.8B | $2.3B |
| Operating income | $2.2B | $1.0B | $1.7B |
| Income tax | $157.0M | $127.0M | $321.0M |
| Net income | $1.6B | $479.0M | $1.3B |
| EPS (diluted) | $8.88 | $2.76 | $7.79 |
| Operating cash flow | $369.0M | $1.2B | $1.9B |
| Free cash flow | -$10.0M | $805.0M | $1.6B |
| Cash & equivalents | $878.0M | $762.0M | $194.0M |
| Inventory | $1.1B | $965.0M | $857.0M |
| Total assets | $14.3B | $14.5B | $13.9B |
| Total liabilities | $9.2B | $11.5B | $2.3B |
| Shareholders' equity | $5.0B | $3.0B | $11.7B |
Growth · year-over-year · Revenue CAGR 0.8%
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue growth | +0.9% | +0.7% | — |
| Net income growth | +224.8% | -64.4% | — |
| EPS growth | +221.7% | -64.6% | — |
| Free cash flow growth | -101.2% | -50.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.